112 related articles for article (PubMed ID: 8222095)
1. Predictive value of tissue plasminogen activator mass concentration on long-term mortality in patients with coronary artery disease. A 7-year follow-up.
Jansson JH; Olofsson BO; Nilsson TK
Circulation; 1993 Nov; 88(5 Pt 1):2030-4. PubMed ID: 8222095
[TBL] [Abstract][Full Text] [Related]
2. Circulating t-PA antigen predicts major adverse coronary events in patients with stable coronary artery disease--a 13-year follow-up.
Niessner A; Graf S; Nikfardjam M; Speidl WS; Huber-Beckmann R; Zorn G; Wojta J; Huber K
Thromb Haemost; 2003 Aug; 90(2):344-50. PubMed ID: 12888883
[TBL] [Abstract][Full Text] [Related]
3. Tissue plasminogen activator and other risk factors as predictors of cardiovascular events in patients with severe angina pectoris.
Jansson JH; Nilsson TK; Olofsson BO
Eur Heart J; 1991 Feb; 12(2):157-61. PubMed ID: 1904350
[TBL] [Abstract][Full Text] [Related]
4. Evidence for increased levels of plasminogen activator inhibitor and tissue plasminogen activator in plasma of patients with angiographically verified coronary artery disease.
Olofsson BO; Dahlén G; Nilsson TK
Eur Heart J; 1989 Jan; 10(1):77-82. PubMed ID: 2495219
[TBL] [Abstract][Full Text] [Related]
5. Plasminogen activator inhibitor activity as a possible indicator of disease activity in rest angina with angiographically insignificant coronary artery stenosis.
Sakata K; Kurata C; Kobayashi A; Rydzewski A; Yamazaki N
Thromb Res; 1991 Sep; 63(5):491-502. PubMed ID: 1755002
[TBL] [Abstract][Full Text] [Related]
6. Endothelial fibrinolytic capacity predicts future adverse cardiovascular events in patients with coronary heart disease.
Robinson SD; Ludlam CA; Boon NA; Newby DE
Arterioscler Thromb Vasc Biol; 2007 Jul; 27(7):1651-6. PubMed ID: 17463331
[TBL] [Abstract][Full Text] [Related]
7. Plasma levels of tissue plasminogen activator and plasminogen activator inhibitor-1 are correlated with the presence of transplant coronary artery disease in cardiac transplant recipients.
Warshofsky MK; Wasserman HS; Wang W; Teng P; Sciacca R; Apfelbaum M; Schwartz A; Michler RE; Mancini DM; Cannon PJ; Rabbani LE
Am J Cardiol; 1997 Jul; 80(2):145-9. PubMed ID: 9230149
[TBL] [Abstract][Full Text] [Related]
8. Changes in plasminogen activator inhibitor 1 and tissue-type plasminogen activator during exercise in patients with coronary artery disease.
Rydzewski A; Sakata K; Kobayashi A; Yamazaki N; Urano T; Takada Y; Takada A
Haemostasis; 1990; 20(5):305-12. PubMed ID: 2127039
[TBL] [Abstract][Full Text] [Related]
9. Relation of depressive mood to plasminogen activator inhibitor, tissue plasminogen activator, and fibrinogen levels in patients with versus without coronary heart disease.
Lahlou-Laforet K; Alhenc-Gelas M; Pornin M; Bydlowski S; Seigneur E; Benetos A; Kierzin JM; Scarabin PY; Ducimetiere P; Aiach M; Guize L; Consoli SM
Am J Cardiol; 2006 May; 97(9):1287-91. PubMed ID: 16635597
[TBL] [Abstract][Full Text] [Related]
10. Increased plasminogen activator inhibitor activity and diabetes predict subsequent coronary events in patients with angina pectoris.
Takazoe K; Ogawa H; Yasue H; Sakamoto T; Soejima H; Miyao Y; Kawano H; Moriyama Y; Misumi K; Suefuji H; Kugiyama K; Yoshimura M
Ann Med; 2001 Apr; 33(3):206-12. PubMed ID: 11370775
[TBL] [Abstract][Full Text] [Related]
11. [Decreased fibrinolytic capacity in coronary patients by increased plasminogen activator inhibitor activity].
Ihnken K; Speiser W; Müller-Berghaus G; Beyersdorf F; Schlepper M; Satter P
Helv Chir Acta; 1992 Jan; 58(4):503-8. PubMed ID: 1582860
[TBL] [Abstract][Full Text] [Related]
12. Transmyocardial fibrinolytic activity in patients with unstable angina pectoris.
Daniel WC; Meidell RS; Hillis LD; Lange RA
Coron Artery Dis; 1996 Jan; 7(1):45-9. PubMed ID: 8773432
[TBL] [Abstract][Full Text] [Related]
13. Fibrinolysis during cardiac surgery. Release of tissue plasminogen activator in arterial and coronary sinus blood.
Valen G; Eriksson E; Risberg B; Vaage J
Eur J Cardiothorac Surg; 1994; 8(6):324-30. PubMed ID: 8086178
[TBL] [Abstract][Full Text] [Related]
14. Circadian fluctuations of plasminogen activator inhibitor and tissue plasminogen activator levels in plasma of patients with unstable coronary artery disease and acute myocardial infarction.
Huber K; Rosc D; Resch I; Schuster E; Glogar DH; Kaindl F; Binder BR
Thromb Haemost; 1988 Dec; 60(3):372-6. PubMed ID: 3149044
[TBL] [Abstract][Full Text] [Related]
15. [Effects of guan-mai-shu on tissue-type plasminogen activator and plasminogen activator inhibitor in the plasma of patients with coronary heart disease].
Xiong XZ; Mo SS
Zhongguo Zhong Xi Yi Jie He Za Zhi; 1993 Dec; 13(12):727-9, 708-9. PubMed ID: 8136646
[TBL] [Abstract][Full Text] [Related]
16. Predictive value of fibrinolytic factors in coronary heart disease.
Wiman B
Scand J Clin Lab Invest Suppl; 1999; 230():23-31. PubMed ID: 10389198
[TBL] [Abstract][Full Text] [Related]
17. Fibrinolytic response to venous occlusion compared to physical stress test in young patients with coronary artery disease.
Nikfardjam M; Graf S; Beckmann R; Hornykewycz S; Koller-Strametz J; Binder BR; Huber K
Thromb Haemost; 1999 Sep; 82 Suppl 1():80-4. PubMed ID: 10695493
[TBL] [Abstract][Full Text] [Related]
18. [Dehydroepiandrosterone therapy in men with angiographically verified coronary heart disease: the effects on plasminogen activator inhibitor-1 (PAI-1), tissue plasminogen activator (tPA) and fibrinogen plasma concentrations].
Rabijewski M; Zgliczyński W
Endokrynol Pol; 2007; 58(3):213-9. PubMed ID: 17940987
[TBL] [Abstract][Full Text] [Related]
19. Baseline fibrinolytic state and the risk of future venous thrombosis. A prospective study of endogenous tissue-type plasminogen activator and plasminogen activator inhibitor.
Ridker PM; Vaughan DE; Stampfer MJ; Manson JE; Shen C; Newcomer LM; Goldhaber SZ; Hennekens CH
Circulation; 1992 May; 85(5):1822-7. PubMed ID: 1572039
[TBL] [Abstract][Full Text] [Related]
20. Plasma tissue plasminogen activator inhibitor levels in coronary artery disease: correlation with age and serum triglyceride concentrations.
Mehta J; Mehta P; Lawson D; Saldeen T
J Am Coll Cardiol; 1987 Feb; 9(2):263-8. PubMed ID: 3100598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
